Matching slides 25,056
Current window 15,361-15,390
Pages 836
Rows per page 30
Beat: Complicationclear collectionreset all

Beat

15,361-15,390 of 25,056

filter-aware
04
This is a classic waterfall-style bridge table presented in a tabular format.3M | Results Presentation Deck | 16 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
3M | Results Presentation Deck | 16 slides3M | Results Presentation Deck | 16 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
03
Uses a comparison to the scale of the universe to frame the problem as an intractable search space.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · Problem1 hit
04
Uses a simple visual metaphor of a subset circle to illustrate the problem of low success rates in drug discovery.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · Problem1 hit
05
Uses a Venn-style diagram to illustrate the small overlap between screening and successful drug candidates.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · Problem1 hit
07
The slide uses a hierarchical diagram to map the clinical manifestations of the disease.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
08
The diagram illustrates the metabolic pathway and the specific block at the Cystathionine beta-synthase step.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
09
The table contrasts clinical outcomes (Hcy levels, lens dislocation, IQ, thrombosis, mortality) between two patient cohorts.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
10
Includes a citation of the specific clinical guidelines paper.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
06
Includes a photo of a child with medical equipment to humanize the disease impact.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · Problem1 hit
05
Aldeyra Therapeutics | Results Presentation Deck | 13 slidesAldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
Uses three distinct visual modules to present market data.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Problem1 hit
13
The slide uses three distinct charts to segment the market by growth, demographics, and ESG sentiment.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Problem1 hit
14
AlTi | Investor Presentation Deck | 46 slidesAlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Problem1 hit
09
The slide uses a comparison frame to justify the market transition.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Problem1 hit
10
Apollo Medical Holdings | Investor Presentation Deck | 45 slidesApollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Problem1 hit
11
The slide uses a hub-and-spoke/process flow hybrid to visualize systemic complexity and administrative burden.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a hub-and-spoke layout to connect the central revenue metric to four key business drivers.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · Need1 hit
02
TCR2 Therapeutics | Results Presentation Deck | 34 slidesTCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
03
TCR2 Therapeutics | Results Presentation Deck | 34 slidesTCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
04
Includes a list of abbreviations at the bottom.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
15
The slide uses a process diagram to illustrate the dose escalation cohorts leading to the Recommended Phase 2 Dose (RP2D).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
05
The slide uses a central hub-and-spoke diagram to show the mast cell as the central point of failure/intervention.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
06
The data highlights the mechanism of action of KIT inhibition (inactivation and depletion) supported by Phase 1b interim results.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
08
The chart uses a combination of bar (quarterly) and line (cumulative) data to demonstrate market acceleration.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
05
The slide uses a before-after comparison for five business metrics, highlighting performance changes in a difficult macro environment.UBS | Results Presentation Deck | 27 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Before After1 hit
25
The chart illustrates the shift in profitability dynamics over the second quarter of 2022.Vulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
26
Vulcan Materials | Investor Day Presentation Deck | 91 slidesVulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
27
Vulcan Materials | Investor Day Presentation Deck | 91 slidesVulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
28
The slide uses a simple horizontal block layout to categorize ESG priorities.Vulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit